Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/IAN stock hub

CSE/IAN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/IANis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

34.9M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/IAN

In the news

Latest news · CSE/IAN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROIC-5.8

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/IAN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	792
Employees Change	-42%
Employees Change Percent	-5.04
Enterprise value	CAD 331.4M
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA45074T1021
Last refreshed	2026-05-10
Market cap	CAD 34.9M
Price	CAD 0.01
Price currency	CAD
Rev Per Employee	265,686.42x
Sector	Healthcare
Sic	2834
Symbol	cse/IAN
Website	https://www.ianthus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-158.11%
EV Earnings	-6.01x
EV/EBITDA	21.3x
EV/FCF	-11.72x
EV/Sales	1.68x
FCF yield	-81.14%
P/B ratio	-0.25x
P/S ratio	0.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-8.73%
EBITDA Margin	3.26%
Gross margin	45.75%
Gross Profit	CAD 90.1M
Gross Profit Growth	-12.54%
Gross Profit Growth Q	-21.18%
Gross Profit Growth3 Y	-4.08%
Gross Profit Growth5 Y	-4.3%
Net Income	CAD -55.1M
Net Income Growth Years	0%
Pretax Margin	-16.13%
Profit Margin	-28%
Profit Per Employee	CAD -74,390
ROA	-2.97
Roa5y	-5.57
ROCE	-6.68
ROIC	-5.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr3y	-30.66%
Cagr5y	-53.7%
EPS Growth Years	0
OCF Growth	-74.92%
OCF Growth Q	5.87%
Revenue Growth	-14.11x
Revenue Growth Q	-17.55x
Revenue Growth Years	0x
Revenue Growth3 Y	-4.06x
Revenue Growth5 Y	-1.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.54
Assets	CAD 351M
Cash	CAD 16M
Current Assets	CAD 66.6M
Current Liabilities	CAD 93.7M
Debt	CAD 312.6M
Debt EBITDA	CAD 20.09
Debt FCF	CAD -11.05
Equity	CAD -141.3M
Interest Coverage	-0.58
Liabilities	CAD 492.3M
Long Term Assets	CAD 284.4M
Long Term Liabilities	CAD 398.6M
Net Cash	CAD -296.6M
Net Cash By Market Cap	CAD -851
Net Debt EBITDA	CAD 46.19
Tangible Book Value	CAD -235.9M
Tangible Book Value Per Share	CAD -0.03
WACC	6.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.71
Inventory Turnover	3.48
Net Working Capital	CAD -33.2M
Quick ratio	0.26
Working Capital	CAD -27.1M
Working Capital Turnover	CAD -19.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	0.01
3Y total return	-66.67%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.87%
All Time High	9.49
All Time High Change	-99.95%
All Time High Date	2018-09-12
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2024-11-06
ATR	0
Beta	-0.92
Beta1y	-1.39
Beta2y	-2.08
High	0.01
High52	0.02
High52 Date	2025-10-30
High52ch	-66.67%
Low	0.01
Low52	0.01
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-3.85%
Price vs 200-day SMA	-26.47%
RSI	48.1
RSI Monthly	34.07
RSI Weekly	42.26
Sharpe ratio	2.44x
Sortino ratio	5.35
Total Return	-2.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -17.2M
Operating margin	-8.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,287,329,189%
Net Borrowing	-16,903,573.3
Shares Insiders	3.98%
Shares Out	6,972,551,786
Shares Qo Q	-0.79%
Shares Yo Y	2.49%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -30.8M
Average Volume	103,227.25x
Bv Per Share	-0.02
CAPEX	CAD -32.6M
Ch3y	-66.67
Ch5y	-97.87
Ch6m	-50
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	23,533,765.8
Dollar Volume	25
Earnings Date	2026-05-11
EBIT	CAD -17.2M
EBITDA	CAD 6.4M
EPS	CAD -0.01
F Score	3
FCF	CAD -28.3M
FCF EV Yield	-8.53x
FCF Per Share	CAD -0
Financing CF	-17,374,833
Fiscal Year End	December
Founded	2,014
Goodwill	2,129,863.9
Income Tax	CAD 23.4M
Investing CF	3,149,463
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Ma150	0.01
Ma150ch	-28.57%
Ma20	0.01
Ma20ch	-5.66%
Net CF	-9,911,826
Next Earnings Date	2026-05-11
Open	0.01
P OCF Ratio	8.08
Ppne	183,414,364.4
Price Date	2026-05-08
Price EBITDA	CAD 5.43
Relative Volume	0.05x
Revenue	196,873,636x
SBC By Revenue	1.28x
Share Based Comp	2,529,716
Tax By Revenue	11.87x
Tr6m	-50%
Volume	5,000
Z Score	-7.15

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/IAN pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/IAN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/IAN?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+4.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.5%

Negative means the company is buying back shares.

Technical

CSE/IAN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.1

Neutral momentum band

Price vs 200-day MA

-26.5%

50/200-day relationship not available

Beta (5Y)

-0.92

Less volatile than the market

Sharpe ratio

2.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/IAN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/IAN stock rating?

cse/IAN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/IAN analysis?

The full report lives at /stocks/cse/IAN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/IAN?

The latest report frames cse/IAN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/IAN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.